Wellgistics Health, Inc. 是一家以藥品和醫療服務為核心的控股公司。公司總部位於佛羅里達州坦帕。該公司在2025年2月21日上市。公司專注於專業藥品和以社區為基礎的模式,為患者提供送藥到家的服務。公司致力於在為藥房、醫療機構、製藥廠和保險支付方提供解決方案的同時,改善患者的生活品質。其技術平台DelivMeds作為一個藥房中心,使臨床服務能夠與公司的健康藥房運營相連接。該平台將提供一個端到端的移動應用程式解決方案,讓患者能夠數位化他們的處方流程。這一解決方案有助於保障患者的自主權、提高處方藥價格透明度,並提供額外的禮賓服務。其產品包括Kyzatrex、司美格魯肽(Semaglutide)和替爾泊肽(Tirzepatide)。
WGRX stock price ended at $0 on 星期四, after dropping NaN%
On the latest trading day Aug 20, 2026, the stock price of WGRX fell by NaN%, dropping from $NaN to $NaN. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $NaN and a high of $NaN. On the latest trading day, the trading volume for WGRX decreased by -- shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, -- shares were traded, with a market value of approximately --.